| Time After Starting | Time After Stopping | AST* (U/L) | Alk P* (U/L) | Bilirubin* (mg/dL) | Other |
|---|---|---|---|---|---|
| Clindamycin (3.6 gm IV daily) started for endocarditis | |||||
| Pre | 30 | 59 | 0.8 | ||
| 5 days | 40 | ||||
| 8 days | 110 | ||||
| 10 days | 310 | ||||
| 14 days | 480 | 1.5 | |||
| 16 days | 710 | Reduced dose | |||
| 3 weeks | 750 | 80 | 3.5 | ||
| 4 weeks | 80 | 1.8 | Liver biopsy | ||
| Fever and urticaria: clindamycin stopped | |||||
| 5 weeks | 4 days | 50 | |||
| 6 weeks | 10 days | 80 | 1.1 | ||
| 7 weeks | 18 days | 160 | Normal | ||
| 2 months | 1 month | 30 | 0.9 | ||
| Normal Values | <40 | <40 | <1.2 | ||
Values estimated from Figure 1.
From: Clindamycin
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.